CSL BEHRING GENE THERAPY INC has a total of 15 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are IXION BIOTECHNOLOGY INC, ONCOGENEX TECHNOLOGIES INC and HUANONG ZHAOQING BIOLOGICAL INDUSTRY TECH RESEARCH INSTITUTE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | United States | 2 | |
#3 | Canada | 1 | |
#4 | Republic of Korea | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Symonds Geoffrey Phillip | 7 |
#2 | Lee Chi-Lin | 6 |
#3 | Breton Louis Randall | 6 |
#4 | Bartlett Jeffrey S | 5 |
#5 | Yan Ming | 4 |
#6 | Bartlett Jeffrey | 4 |
#7 | Boyd Maureen | 3 |
#8 | Suzuki Kazuo | 3 |
#9 | Kelleher Anthony Dominic | 3 |
#10 | Chen Irvin | 3 |
Publication | Filing date | Title |
---|---|---|
SG11202101594WA | Vector production in serum free media | |
AU2015213417A1 | Dual vector for inhibition of human immunodeficiency virus |